Amphotericin B lipid complex as prophyla
β
Gloria N. Mattiuzzi; Hagop Kantarjian; Stefan Faderl; JoAnn Lim; Dimitrios Konto
π
Article
π
2004
π
John Wiley and Sons
π
English
β 107 KB
## Abstract ## BACKGROUND The optimal antifungal prophylactic regimen for patients with acute myelogenous leukemia (AML) or highβrisk myelodysplastic syndrome (MDS) undergoing induction chemotherapy has yet to be identified. A prospective historical control study evaluated the efficacy and safety